108 related articles for article (PubMed ID: 21656602)
1. Androgen-independent effects of Serenoa repens extract (Prostasan®) on prostatic epithelial cell proliferation and inflammation.
Iglesias-Gato D; Carsten T; Vesterlund M; Pousette A; Schoop R; Norstedt G
Phytother Res; 2012 Feb; 26(2):259-64. PubMed ID: 21656602
[TBL] [Abstract][Full Text] [Related]
2. Hexanic lipidosterolic extract of Serenoa repens inhibits the expression of two key inflammatory mediators, MCP-1/CCL2 and VCAM-1, in vitro.
Latil A; Libon C; Templier M; Junquero D; Lantoine-Adam F; Nguyen T
BJU Int; 2012 Sep; 110(6 Pt B):E301-7. PubMed ID: 22520557
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cell death caused by an ethanolic extract of Serenoae repentis fructus (Prostasan) on human carcinoma cell lines.
Hostanska K; Suter A; Melzer J; Saller R
Anticancer Res; 2007; 27(2):873-81. PubMed ID: 17465214
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the potency of different brands of Serenoa repens extract on 5alpha-reductase types I and II in prostatic co-cultured epithelial and fibroblast cells.
Scaglione F; Lucini V; Pannacci M; Caronno A; Leone C
Pharmacology; 2008; 82(4):270-5. PubMed ID: 18849646
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor transactivation is implicated in IL-6-induced proliferation and ERK1/2 activation in non-transformed prostate epithelial cells.
Poncet N; Guillaume J; Mouchiroud G
Cell Signal; 2011 Mar; 23(3):572-8. PubMed ID: 21111811
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory properties of Lipidosterolic extract of Serenoa repens (Permixon®) in a mouse model of prostate hyperplasia.
Bernichtein S; Pigat N; Camparo P; Latil A; Viltard M; Friedlander G; Goffin V
Prostate; 2015 May; 75(7):706-22. PubMed ID: 25683150
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the potency of 10 different brands of Serenoa repens extracts.
Scaglione F; Lucini V; Pannacci M; Dugnani S; Leone C
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):569-74. PubMed ID: 22774395
[TBL] [Abstract][Full Text] [Related]
8. Crocus sativus, Serenoa repens and Pinus massoniana extracts modulate inflammatory response in isolated rat prostate challenged with LPS.
Chiavaroli A; Recinella L; Ferrante C; Locatelli M; Carradori S; Macchione N; Zengin G; Leporini L; Leone S; Martinotti S; Brunetti L; Vacca M; Menghini L; Orlando G
J Biol Regul Homeost Agents; 2017 Jul-Sep,; 31(3):531-541. PubMed ID: 28889734
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of epidermal growth factor receptor signaling by Saussurea involucrata, a rare traditional Chinese medicinal herb, in human hormone-resistant prostate cancer PC-3 cells.
Way TD; Lee JC; Kuo DH; Fan LL; Huang CH; Lin HY; Shieh PC; Kuo PT; Liao CF; Liu H; Kao JY
J Agric Food Chem; 2010 Mar; 58(6):3356-65. PubMed ID: 20166659
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the DHT-induced PSA secretion by Verbascum xanthophoeniceum and Serenoa repens extracts in human LNCaP prostate epithelial cells.
Marcoccia D; Georgiev MI; Alipieva KI; Lorenzetti S
J Ethnopharmacol; 2014 Aug; 155(1):616-25. PubMed ID: 24928827
[TBL] [Abstract][Full Text] [Related]
11. Lipido-sterolic extract of Serenoa repens (LSESr, Permixon) treatment affects human prostate cancer cell membrane organization.
Petrangeli E; Lenti L; Buchetti B; Chinzari P; Sale P; Salvatori L; Ravenna L; Lococo E; Morgante E; Russo A; Frati L; Di Silverio F; Russo MA
J Cell Physiol; 2009 Apr; 219(1):69-76. PubMed ID: 19067321
[TBL] [Abstract][Full Text] [Related]
12.
Saponaro M; Giacomini I; Morandin G; Cocetta V; Ragazzi E; Orso G; Carnevali I; Berretta M; Mancini M; Pagano F; Montopoli M
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276425
[TBL] [Abstract][Full Text] [Related]
13. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
Siu SW; Lau KW; Tam PC; Shiu SY
Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
[TBL] [Abstract][Full Text] [Related]
14. Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin.
Madarame J; Higashiyama S; Kiyota H; Madachi A; Toki F; Shimomura T; Tani N; Oishi Y; Matsuura N
Prostate; 2003 Nov; 57(3):187-95. PubMed ID: 14518027
[TBL] [Abstract][Full Text] [Related]
15. Extracts from Pygeum africanum and other ethnobotanical species with antiandrogenic activity.
Schleich S; Papaioannou M; Baniahmad A; Matusch R
Planta Med; 2006 Jul; 72(9):807-13. PubMed ID: 16783690
[TBL] [Abstract][Full Text] [Related]
16. The combination of Serenoa repens, selenium and lycopene is more effective than serenoa repens alone to prevent hormone dependent prostatic growth.
Altavilla D; Bitto A; Polito F; Irrera N; Marini H; Arena S; Favilla V; Squadrito F; Morgia G; Minutoli L
J Urol; 2011 Oct; 186(4):1524-9. PubMed ID: 21855911
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H
Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor monoclonal antibody inhibits constitutive receptor phosphorylation, reduces autonomous growth, and sensitizes androgen-independent prostatic carcinoma cells to tumor necrosis factor alpha.
Fong CJ; Sherwood ER; Mendelsohn J; Lee C; Kozlowski JM
Cancer Res; 1992 Nov; 52(21):5887-92. PubMed ID: 1394216
[TBL] [Abstract][Full Text] [Related]
19. [A comparative analysis of the effectiveness of serenoa repens and serenoa repens in combination with urtica dioiccus for lower urinary symptoms suggestive of benign prostatic hyperplasia associated with chronic inflammation in prostate tissue].
Ibishev KS; Krainy PA; Mitusov VV; Sizyakin DV; Magomedov GA
Urologiia; 2019 Apr; (1):40-46. PubMed ID: 31184016
[TBL] [Abstract][Full Text] [Related]
20. The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells.
Kundu SD; Lee C; Billips BK; Habermacher GM; Zhang Q; Liu V; Wong LY; Klumpp DJ; Thumbikat P
Prostate; 2008 Feb; 68(2):223-9. PubMed ID: 18092352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
